0 items USD 0.00Search
Your search for "hjresearch global alzheimers disease treatments industry market research 2019" gave back 961 results.
Cervical cancer is one of the most prevalent forms of cancer affecting women all over the world. In most cases, the disease is attributed to genital...
Catalog:
iGATE
July 2017
Price: USD 1,890.00
With much-awaited approval of biosimilar interchangeability by FDA, the dynamics in the much nascent US biosimilars market is about to change with...
Catalog:
Rockville Research
January 2017
Price: USD 1,200.00
India In-Vitro Diagnostics (IVD) market is likely to exceed US$ 1.8 Billion mark by 2025. The IVD industry in India has been witnessing immense...
Catalog:
iGATE
April 2019
Price: USD 1,590.00
Pet Healthcare in India - Market Summary, Competitive Analysis and Forecast to 2024 Summary Pet Healthcare in India industry profile provides top-...
Catalog:
MarketLine
May 2021
Price: USD 350.00
Cipla Limited - Strategy, SWOT and Corporate Finance Report Summary Cipla Limited - Strategy, SWOT and Corporate Finance Report, is a source of...
MarketLine
January 2023
Price: USD 175.00
Asia proton therapy market is anticipated to almost three-fold during the period 2016 – 2022. The number of proton therapy centers is continuously...
Catalog:
iGATE
May 2017
Price: USD 1,450.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Chemical, Industrial & Pharmaceutical Laboratories, now known as...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. From being an enzyme venture, Biocon successfully emerged as a...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. The business segments of Lupin mainly comprise of APIs and...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Ipca Labs was founded by K.B. Mehla and Dr. N.S. Tibrawala in 1949...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. The business segments of Divis labs are Active Pharma Ingredients,...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. The key business segments of Aurobindo Pharma are APIs, Formulations...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Abbott India Limited is a public listed company and a subsidiary of...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Torrent Pharmaceuticals Limited is the 8th largest pharmaceutical...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Sun Pharmaceuticals is a multinational company and was established by...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
